B5.026 - Liver Disorders 2 Flashcards
causes of viral hepatitis
EBV
CMV
Yellow fever
herpes
viral hepititis
herpes hepatitis features
immunocompromised pts
patchy coagulative necrosis, no particular zonal distribution
eosinophilic intranuclear inclusions
3 M’s of Herpes
Multinucleation
Molding
Margination
CMV hepatitis features
mostly after renal and liver transplant
immunocompetent people - mono with mild hepatitis
histo of CMV hepatitis
focal hepatocyte necrosis, microabscesses, occasional sinusodal lymphocytic infiltration, owls eye
CMV hepatitis
intranuclear inclusions
microabscesses in CMV hepatitis
feature of EBV hepatitis
immunocompetent and compromised
diffuse sinusoidal lymphocytic infiltrate with varying degrees of portal inflammation “string of pearls”
sinusoidal lymphoctytosis in EBV hepatitis
hepatitis A features
endemic in countries with substandard sanitation
sporadic
fecal oral
1992
hepatitis B features
1/3 world pop infected
chronic or acute
transmission of HBV
perinatal
sexual contacts
IV drugs
transfusion
natural history of HBV
injury from HBV
injury caused by CD8+ cytotoxic T cells attacking infected cells
HBV histo
ground glass hepatocytes
cells with endoplasmic retuculum swollen with HSsAg
HBV ground glass hepatocytes
most common blood bourne infection in US
HCV
HCV transmission
inoculations and blood transfusions
IV drug use - 60%
transfusions
hemodialysis and healtcare workers
natural history of HCV
HDV features
unique RNA virus that is replication defective
only causes infection when encapsulated by HBsAg
Dependent on HBV for multiplication
HEV features
enterically transmitted, water bourne
mostly self limiting, except in high mortality in pregnant women
sinusodal lymphocytes and kupffer cells top
apoptotic hepatocyte bottom
acute hepatitis
normal liver
clinically chronic hepatitis
presistent inflammatory reaction of the liver with more than 6 months of linical signs and symptoms
maked patchy expansion of the portal tracts by predominantly lymphocytes, interface hepatitis, varying degrees of bile duct damage, steatosis, lobular inflammation
grade and stage for chronic hepatitis C
grade - activity
stage - fibrosis
what is harvoni
treatment of genotype 1 of hepatitis C
one pill, once a day
in clinical studies 96-99% of patients who had no prior treatment were cured in 12 weeks of therapy
combo of sofosbuvir, ledipasvir
what are sofosbuvir and ledipasvir
sofosbuvir - nucleotide polymerase inhibitor
ledipasvir - NS5A inhibitor
what are factors that are taken into account in activity (grade) of chronic hepatitis C
portal inflammation
interface hepatitis
confluent necrosis
apoptosis
portal inflammation
interface hepatitis
confluent necrosis
apoptosis and lobular inflammation